Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29330302
Publication Date : //

Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors.


Breast cancer development and progression are influenced by insulin-like growth factor receptor 1 (IGF1R) and insulin receptor (InsR) signaling, which drive cancer phenotypes such as cell growth, proliferation, and migration. IGF1R and InsR form IGF1R/InsR hybrid receptors (HybRs) consisting of one molecule of IGF1R and one molecule of InsR. The specific signaling and functions of HybR are largely unknown, as HybR is activated by both IGF1 and insulin, and no cellular system expresses HybR in the absence of holo-IGF1R or holo-InsR. Here we studied the role of HybR by constructing inducible chimeric receptors and compared HybR signaling with that of holo-IGF1R and holo-InsR. We cloned chemically inducible chimeric IGF1R and InsR constructs consisting of the extracellular domains of the p75 nerve growth factor receptor fused to the intracellular β subunit of IGF1R or InsR and a dimerization domain. Dimerization with the drugs AP20187 or AP21967 allowed specific and independent activation of holo-IGF1R, holo-InsR, or HybR, resulting in activation of the PI3K pathway. Holo-IGF1R and HybR both promoted cell proliferation and glucose uptake, whereas holo-InsR only promoted glucose uptake, and only holo-IGF1R showed anti-apoptotic effects. We also found that the three receptors differentially regulated gene expression: holo-IGF1R and HybR up-regulated EGR3; holo-InsR specifically down-regulated JUN and BCL2L1; holo-InsR down-regulated but HybR up-regulated HK2; and HybR specifically up-regulated FHL2, ITGA6, and PCK2. Our findings suggest that, when expressed and activated in mammary epithelial cells, HybR acts in a manner similar to IGF1R and support further investigation of the role of HybR in breast cancer.

Authors : Chen Jingci , Nagle Alison M , Wang Yu-Fen , Boone David N , Lee Adrian V ,

Related products :

Catalog number Product name Quantity
orb61268 Motesanib (Free base) Motesanib (AMG 706) is an experimental drug candidate. It is an orally administered small molecule antagonist of VEGF receptors, platelet-derived growth factor receptors, and ste 10 mg
orb61267 Motesanib diphosphate Motesanib is an experimental drug candidate. It is an orally administered small molecule antagonist of VEGF receptors, platelet-derived growth factor receptors, and stem cell fac 10 mg
25-180 Retinoid X receptors (RXRs) and retinoic acid receptors (RARs), are nuclear receptors that mediate the biological effects of retinoids by their involvement in retinoic acid-mediated gene activation. T 0.05 mg
18-783-78916 RABBIT ANTI HUMAN INSULIN-LIKE GROWTH FACTOR II Biotin - INSULIN-LIKE GROWTH FACTOR II; IGF-II; Somatomedin-A Polyclonal 0.05 mg
18-783-76101 GOAT ANTI MOUSE INSULIN-LIKE GROWTH FACTOR I Biotin - INSULIN-LIKE GROWTH FACTOR I; Polyclonal 0.05 mg
18-783-78409 RABBIT ANTI HUMAN INSULIN-LIKE GROWTH FACTOR II - INSULIN-LIKE GROWTH FACTOR II; IGF-II; Somatomedin-A Polyclonal 0.1 mg
18-783-76100 GOAT ANTI MOUSE INSULIN-LIKE GROWTH FACTOR I - INSULIN-LIKE GROWTH FACTOR I; Polyclonal 0.1 mg
IQ391 Mouse Anti-Insulin-Like Growth Factor (IGF-1) Target Antigen Insulin-Like Growth Factor (IGF-1) Host Isotype Mouse IgG1 Application RIA or EIA assay development & studies of IGF-1 on frozen & paraf 0.1ml (1mg/ml)
20-783-73396 MOUSE ANTI INSULIN-LIKE GROWTH FACTOR I - INSULIN-LIKE GROWTH FACTOR 1; Monoclonal 0.2 mg
10-783-79118 RECOMBINANT MOUSE INSULIN-LIKE GROWTH FACTOR I - INSULIN-LIKE GROWTH FACTOR I; 0.01 mg
10-783-79015 RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR II - INSULIN-LIKE GROWTH FACTOR II; 0.05 mg
31-110 GRIA2 is one of the glutamate receptors, which are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. The 0.1 mg
31-145 Receptors for the C-C chemokine family include CKR-I, CKR-2A, CKR-3, CKR-4, CKR- 5 and the Duffy blood group antigen. The C-C receptors are important in the function of T cell chemotaxis and migration 0.1 mg
orb82712 Human IGFI protein Insulin-like Growth Factor 1 (IGF1) is similar to insulin in function and structure and is amember of a family of proteins involved in mediating growth and development. IGF1 isproce 1 mg
26-475 Receptors for the Fc fragment of IgG, or FCGRs, are cell surface glycoproteins of the Ig superfamily (IgSF). These receptors mediate phagocytosis of IgG-coated pathogens and promote activation of effe 0.05 mg
P3668Rb Rabbit anti_ kilodalton growth factor receptors p 40ug/0.2ml
25-760 Upon ligand binding, G protein-coupled receptors, such as GPR161, activate cytoplasmic G proteins (see GNAS, MIM 139320), allowing the receptors to transduce extracellular signals across the plasma me 0.05 mg
26-179 Paired receptors consist of highly related activating and inhibitory receptors and are widely involved in the regulation of the immune system. PILRB is thought to act as a cellular signaling activatin 0.05 mg
EL10010 Epidermal Growth Factor (EGF) ELISA Kits for Human Cytokines and Receptors 96-well
MEC1012 Transforming Growth Factor β1 (TGF-β1) ELISA Kits for Mouse Cytokines and Receptors 96-well
18-783-77855 SHEEP ANTI HUMAN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 - INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; Polyclonal 1 ml
20-783-73397 MOUSE ANTI HUMAN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 - INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; Monoclonal 0.2 mg
20-783-73398 MOUSE ANTI HUMAN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 - INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; Monoclonal 0.2 mg
29-386 KHDRBS1 recruited and tyrosine phosphorylated by several receptor systems, for example the T-cell, leptin and insulin receptors. Once phosphorylated, KHDRBS1 functions as an adapter protein in signal 0.05 mg
EL10048 Basic Fibroblast Growth Factor (b-FGF) ELISA Kits for Human Cytokines and Receptors 96-well


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur